Clinical Trial to Evaluate the Safety and Immunogenicity of Mumps Vaccine

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2020
The purpose of this study is to evaluate the safety and immunogenicity of mumps vaccine in healthy infants aged 8-12months, compared with measles, mumps and rubella combined vaccine, live (MMRV).
Epistemonikos ID: c883500c1e7ba651297f083099357a19f632fd44
First added on: Dec 20, 2022